Hamish S. Sutherland

1.2k total citations
29 papers, 940 citations indexed

About

Hamish S. Sutherland is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Hamish S. Sutherland has authored 29 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Infectious Diseases and 12 papers in Organic Chemistry. Recurrent topics in Hamish S. Sutherland's work include Tuberculosis Research and Epidemiology (16 papers), Cancer therapeutics and mechanisms (10 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (5 papers). Hamish S. Sutherland is often cited by papers focused on Tuberculosis Research and Epidemiology (16 papers), Cancer therapeutics and mechanisms (10 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (5 papers). Hamish S. Sutherland collaborates with scholars based in New Zealand, United States and Canada. Hamish S. Sutherland's co-authors include William A. Denny, Brian D. Palmer, Scott G. Franzblau, Adrian Blaser, Andrew M. Thompson, Zhenkun Ma, Baojie Wan, Iveta Kmentová, Christopher B. Cooper and Peter J. Choi and has published in prestigious journals such as Chemical Communications, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Hamish S. Sutherland

29 papers receiving 918 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hamish S. Sutherland New Zealand	15	517	423	411	203	87	29	940
Adrian Blaser New Zealand	22	708 1.4×	465 1.1×	599 1.5×	283 1.4×	93 1.1×	30	1.3k
Amit Nayyar India	13	358 0.7×	296 0.7×	464 1.1×	136 0.7×	110 1.3×	20	790
Christopher B. Cooper United States	21	684 1.3×	522 1.2×	502 1.2×	287 1.4×	107 1.2×	47	1.3k
Giulio Cesare Porretta Italy	18	441 0.9×	490 1.2×	777 1.9×	310 1.5×	86 1.0×	29	1.3k
Robin B. Lee United States	15	403 0.8×	324 0.8×	311 0.8×	168 0.8×	51 0.6×	20	805
Thierry Masquelin United States	23	510 1.0×	344 0.8×	579 1.4×	198 1.0×	95 1.1×	39	1.2k
Nicolas Willand France	20	606 1.2×	411 1.0×	408 1.0×	193 1.0×	134 1.5×	58	1.2k
Jiyoun Nam South Korea	12	326 0.6×	202 0.5×	256 0.6×	200 1.0×	32 0.4×	19	671
K. Raja Reddy United States	17	483 0.9×	219 0.5×	472 1.1×	161 0.8×	26 0.3×	26	1.1k
Jonnalagadda Padma Sridevi India	24	518 1.0×	388 0.9×	686 1.7×	80 0.4×	82 0.9×	36	1.0k

Countries citing papers authored by Hamish S. Sutherland

Since Specialization

Citations

This map shows the geographic impact of Hamish S. Sutherland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamish S. Sutherland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamish S. Sutherland more than expected).

Fields of papers citing papers by Hamish S. Sutherland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamish S. Sutherland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamish S. Sutherland. The network helps show where Hamish S. Sutherland may publish in the future.

Co-authorship network of co-authors of Hamish S. Sutherland

This figure shows the co-authorship network connecting the top 25 collaborators of Hamish S. Sutherland. A scholar is included among the top collaborators of Hamish S. Sutherland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamish S. Sutherland. Hamish S. Sutherland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anderson, Robert F., Hamish S. Sutherland, & Andrew J. Marshall. (2025). Chain-release of quinoline-based drugs from N-alkoxyquinoline prodrugs upon radiolytic one-electron reduction. Chemical Communications. 61(54). 9968–9971. 1 indexed citations

Sutherland, Hamish S., Peter J. Choi, Guo‐Liang Lu, et al.. (2022). Synthesis and Structure–Activity Relationships for the Anti-Mycobacterial Activity of 3-Phenyl-N-(Pyridin-2-ylmethyl)Pyrazolo[1,5-a]Pyrimidin-7-Amines. Pharmaceuticals. 15(9). 1125–1125. 6 indexed citations

Sutherland, Hamish S., Guo‐Liang Lu, Amy S.T. Tong, et al.. (2021). Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis. European Journal of Medicinal Chemistry. 229. 114059–114059. 9 indexed citations

Choi, Peter J., Guo‐Liang Lu, Hamish S. Sutherland, et al.. (2021). Synthetic studies towards isomeric pyrazolopyrimidines as potential ATP synthesis inhibitors of Mycobacterium tuberculosis. Structural correction of reported N-(6-(2-(dimethylamino)ethoxy)-5-fluoropyridin-3-yl)-2-(4-fluorophenyl)-5-(trifluoromethyl)pyrazolo[1,5-α]pyrimidin-7-amine. Tetrahedron Letters. 90. 153611–153611. 11 indexed citations

Lu, Guo‐Liang, Amy S.T. Tong, Daniel Conole, et al.. (2020). Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry. 28(22). 115784–115784. 18 indexed citations

Choi, Peter J., Daniel Conole, Hamish S. Sutherland, et al.. (2020). Synthetic Studies to Help Elucidate the Metabolism of the Preclinical Candidate TBAJ-876—A Less Toxic and More Potent Analogue of Bedaquiline. Molecules. 25(6). 1423–1423. 11 indexed citations

Blaser, Adrian, Hamish S. Sutherland, Amy S.T. Tong, et al.. (2019). Structure-activity relationships for unit C pyridyl analogues of the tuberculosis drug bedaquiline. Bioorganic & Medicinal Chemistry. 27(7). 1283–1291. 40 indexed citations

Sutherland, Hamish S., Amy S.T. Tong, Peter J. Choi, et al.. (2019). 3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel. Bioorganic & Medicinal Chemistry. 27(7). 1292–1307. 81 indexed citations

Sutherland, Hamish S., Amy S.T. Tong, Peter J. Choi, et al.. (2019). Variations in the C-unit of bedaquiline provides analogues with improved biology and pharmacology. Bioorganic & Medicinal Chemistry. 28(1). 115213–115213. 29 indexed citations

10.

Sutherland, Hamish S., Amy S.T. Tong, Peter J. Choi, et al.. (2018). Structure-activity relationships for analogs of the tuberculosis drug bedaquiline with the naphthalene unit replaced by bicyclic heterocycles. Bioorganic & Medicinal Chemistry. 26(8). 1797–1809. 59 indexed citations

11.

Choi, Peter J., Hamish S. Sutherland, Amy S.T. Tong, et al.. (2017). Synthesis and evaluation of analogues of the tuberculosis drug bedaquiline containing heterocyclic B-ring units. Bioorganic & Medicinal Chemistry Letters. 27(23). 5190–5196. 48 indexed citations

12.

Tong, Amy S.T., Peter J. Choi, Adrian Blaser, et al.. (2017). 6-Cyano Analogues of Bedaquiline as Less Lipophilic and Potentially Safer Diarylquinolines for Tuberculosis. ACS Medicinal Chemistry Letters. 8(10). 1019–1024. 60 indexed citations

13.

Bishop, Karen, Hamish S. Sutherland, Gareth Marlow, et al.. (2016). A quinazoline-based HDAC inhibitor affects gene expression pathways involved in cholesterol biosynthesis and mevalonate in prostate cancer cells. Molecular BioSystems. 12(3). 839–849. 7 indexed citations

14.

Sutherland, Hamish S., In Young Hwang, Elaine S. Marshall, et al.. (2011). Therapeutic reactivation of mutant p53 protein by quinazoline derivatives. Investigational New Drugs. 30(5). 2035–2045. 8 indexed citations

15.

Thompson, Andrew M., Hamish S. Sutherland, Brian D. Palmer, et al.. (2011). Synthesis and Structure–Activity Relationships of Varied Ether Linker Analogues of the Antitubercular Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824). Journal of Medicinal Chemistry. 54(19). 6563–6585. 99 indexed citations

16.

Kmentová, Iveta, Hamish S. Sutherland, Brian D. Palmer, et al.. (2010). Synthesis and Structure−Activity Relationships of Aza- and Diazabiphenyl Analogues of the Antitubercular Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824). Journal of Medicinal Chemistry. 53(23). 8421–8439. 68 indexed citations

17.

Souza, Fabio E. S., et al.. (2002). A Two-Step Conversion of α,β-Unsaturated Ketones to Their α-Carbalkoxy or α-Carbamoyl Derivatives. The Journal of Organic Chemistry. 67(18). 6568–6570. 12 indexed citations

18.

Sutherland, Hamish S., Fabio E. S. Souza, & Russell Rodrigo. (2001). A Short Synthesis of (±)-Halenaquinone. The Journal of Organic Chemistry. 66(10). 3639–3641. 32 indexed citations

19.

Woodgate, Paul D., Hamish S. Sutherland, & Clifton E. F. Rickard. (2001). Insertion of alkynes into diterpenoid chromium aminocarbenes: synthesis of ring-C aromatic steroidal analogues. Journal of Organometallic Chemistry. 627(2). 206–220. 7 indexed citations

20.

Woodgate, Paul D., Hamish S. Sutherland, & Clifton E. F. Rickard. (2001). Synthesis of chromium aminocarbene complexes of diterpenoids. Journal of Organometallic Chemistry. 626(1-2). 199–220. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact